HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection from lethal coronavirus infection by immunoglobulin fragments.

Abstract
Molecular mechanisms of in vitro and in vivo virus neutralization by specific Ab remain largely undefined. Murine coronaviruses provide an excellent animal model for such studies. To determine the role of Ab bivalency and the contribution of its Fc portion in the neutralization of viral infectivity and passive protection of mice by an in vitro neutralizing and in vivo protective mAb (7-10A), F(ab')2 and Fab fragments were generated and their biologic properties were examined. The two fragments reacted in ELISA like the whole Ab against viral Ag or specific anti-idiotypic Abs. The affinity constants of the different Ab preparations were determined by surface plasmon resonance using immobilized anti-idiotypic Abs. The apparent affinity constant of the whole Ab molecule was 7.0 x 10(9) M-1 and was reduced 2-fold for F(ab')2 fragments and 14-fold for Fab molecules. Like whole Ab, both F(ab')2 and Fab fragments could neutralize virus in vitro and passively protect mice in vivo. However, the efficiency of in vivo neutralization by Fab fragments was reduced compared with the bivalent molecules, despite almost identical half-lives of both types of Ab fragments. These results demonstrate that in vitro and in vivo virus neutralization mechanisms by this Ab are independent of Fc-mediated functions and bivalency, but are probably influenced by Ab avidity. Also, this is the first report of in vivo protection against a viral infection by Fab fragments of antiviral Ab.
AuthorsA Lamarre, P J Talbot
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 154 Issue 8 Pg. 3975-84 (Apr 15 1995) ISSN: 0022-1767 [Print] United States
PMID7706736 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Hepatitis Antibodies
  • Immunoglobulin Fab Fragments
  • Membrane Glycoproteins
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins
Topics
  • Animals
  • Antibodies, Anti-Idiotypic (immunology)
  • Antibodies, Monoclonal (immunology)
  • Coronavirus Infections (immunology, prevention & control)
  • Encephalitis, Viral (prevention & control)
  • Female
  • Hepatitis Antibodies (immunology)
  • Hepatitis, Viral, Animal (immunology, prevention & control)
  • Immunization, Passive
  • Immunoglobulin Fab Fragments (metabolism, therapeutic use)
  • Male
  • Membrane Glycoproteins (immunology)
  • Metabolic Clearance Rate
  • Mice
  • Mice, Inbred BALB C
  • Murine hepatitis virus (immunology)
  • Neutralization Tests
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: